NCT07301684

Brief Summary

The objective of this clinical trial is to determine whether therapeutic physical exercise combined with electrotherapy and exercise gaming improves rehabilitation outcomes in pediatric and adolescent cancer patients. The main questions it aims to answer are: Does the combination of therapeutic physical exercise plus muscle strengthening and therapeutic physical exercise plus gamification, compared to a single exercise intervention, improve patient condition? Does gamified exercise improve treatment adherence? Does electrotherapy improve muscle activity when used in muscle strengthening mode? Researchers will test the application of the described modalities and assess improvements in variables such as cardiorespiratory fitness, physical activity self-efficacy, pain, balance, joint range of motion, physical activity level, cancer-related fatigue, quality of life, anxiety-depression, sleep, kinesophobia, and social status.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
4mo left

Started Feb 2026

Shorter than P25 for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress45%
Feb 2026Sep 2026

First Submitted

Initial submission to the registry

November 24, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 24, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

February 1, 2026

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Expected
Last Updated

January 9, 2026

Status Verified

November 1, 2025

Enrollment Period

28 days

First QC Date

November 24, 2025

Last Update Submit

January 7, 2026

Conditions

Keywords

pediatricsoncology

Outcome Measures

Primary Outcomes (11)

  • Strength

    30-second sit-to-stand test to measure lower extremity muscle performance: is a functional measure of lower-limb strength in which an individual stands up and sits down from a chair as many times as possible within 30 seconds. If the test is reported using a numerical score, it corresponds to the total number of completed sit-to-stand repetitions, where the minimum value is 0, the maximum value depends on the person's performance, and higher scores indicate better lower-body strength and functional capacity.

    6 month

  • Cardiorespiratory function

    6-minute walk test: is a widely used assessment of cardiorespiratory function in which an individual is instructed to walk as far as possible along a flat, measured course for six minutes. When reported numerically, the score corresponds to the total distance walked in meters, with a minimum value of 0 meters, no fixed maximum (as it depends on individual performance), and higher distances indicating better cardiorespiratory capacity and endurance.

    6 month

  • Physical activity self-efficacy

    The five-item Physical Activity Self-Efficacy Scale (PASE): is a brief self-report measure that evaluates an individual's confidence in their ability to engage in physical activity under various challenging circumstances. Scores are obtained by summing responses to the five items, each typically rated on a scale from 1 (low confidence) to 5 (high confidence), yielding a minimum total score of 5 and a maximum of 25. Higher scores indicate better self-efficacy for maintaining physical activity.

    6 month

  • Pain level

    Visual Analog Scale (VAS): is a simple, widely used measure for assessing the intensity of subjective experiences such as pain, fatigue, or discomfort. It typically consists of a 10-centimeter horizontal line anchored by verbal descriptors at each end-for example, 0 = "no pain" and 10 = "worst imaginable pain." The respondent marks a point on the line that represents their perceived intensity. The minimum score is 0, the maximum score is 10, and higher scores indicate a worse symptom intensity.

    6 month

  • Balance

    Pediatric Berg Balance Scale (BBS): is a performance-based assessment designed to measure functional balance in children through 14 tasks such as standing, turning, and reaching. Each item is scored from 0 (inability to perform) to 4 (independent, best performance), producing a minimum total score of 0 and a maximum of 56. Higher scores indicate better balance ability and greater functional stability.

    6 month

  • Ankle dorsiflexion ROM

    Goniometer: is an instrument used to measure the range of motion (ROM) of a joint. For ankle dorsiflexion, the goniometer is positioned with the axis at the lateral malleolus, the stationary arm aligned with the fibula, and the movable arm along the fifth metatarsal. Measurements are reported in degrees, with a typical minimum of 0° and a maximum depending on the individual, usually around 20° for dorsiflexion. Higher values indicate greater ankle dorsiflexion ROM, reflecting better joint flexibility.

    6 month

  • Weight

    Tanita DC-439 MA

    6 month

  • Height

    Harpender stadiometer

    6 month

  • BMI

    weight/height 2

    6 month

  • Bone mineral density

    Ultrasound (QUS Model: Bone Mineral Densiometer, (OSTEOSYS, BETTER PRODUCTS FOR BETTER LIFE, n.d.))

    6 month

  • Muscle circumferences (upper arm, waist, hip, and thigh)

    Tape measure

    6 month

Secondary Outcomes (8)

  • Physical activity levels

    6 month

  • Cancer-related fatigue

    6 month

  • Cancer-related Quality of life

    6 month

  • Anxiety-depressive symptoms

    6 month

  • Sleep

    6 month

  • +3 more secondary outcomes

Study Arms (3)

GROUP EXERCISE

ACTIVE COMPARATOR
Other: Therapeutic physical exercise

GROUP ELECTROTHERAPY

ACTIVE COMPARATOR
Other: Therapeutic physical exercise + electrotherapy

GROUP EXERGAMING

ACTIVE COMPARATOR
Other: Therapeutic physical exercise + gamified game

Interventions

Specific therapeutic exercise intervention based on FITT parameters and working with aerobic, anaerobic, and breathing exercises.

GROUP EXERCISE

Specific therapeutic exercise intervention based on FITT parameters and working with aerobic, anaerobic, and breathing exercises. Combined with the application of electrical waves for neurostimulation of the quadriceps muscles.

GROUP ELECTROTHERAPY

Specific therapeutic exercise intervention based on FITT parameters and focusing on aerobic, anaerobic, and breathing exercises. Combined with the application of gamified exercise to improve treatment adherence in these young populations.

GROUP EXERGAMING

Eligibility Criteria

Age3 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patients who have completed cancer treatment and are currently in remission, referred by their oncologist.
  • Children and adolescents aged 3 to 16 years.
  • Patients with a stable medical condition, without severe or acute complications related to cancer or its treatments.
  • Patients whose informed consent (from parents/legal guardians, in this case, as they are minors) has been obtained to participate in this study.
  • Patients with sufficient physical capacity to tolerate the activities proposed by the program.

You may not qualify if:

  • Severe comorbidities: neuromuscular, cardiovascular, or respiratory diseases that prevent participation in the exercise program or interfere with the assessment of physical function.
  • Incompatible medical treatments: patients currently receiving active treatments or with medical contraindications for electrotherapy or participation in exercise programs.
  • Severe psychological issues: children with severe psychological disorders or cognitive disabilities that may hinder understanding and participation in the sessions.
  • Visual impairments: patients with visual problems will not be able to participate, as this may interfere with the analysis of results related to the use of devices and video games for exercise.
  • Participation in other clinical trials: patients already involved in other research that could interfere with the results of this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Facultad de Enfermería, Fisioterapia y Podología

Seville, 41006, Spain

Location

MeSH Terms

Conditions

Neoplasms

Interventions

Electric Stimulation Therapy

Intervention Hierarchy (Ancestors)

TherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • MANOLO M ALBORNOZ CABELLO, FISIOTERAPEUTA

    FACULTAD DE ENFERMERÓIA, FISIOTERAPIA Y PODOLOGÍA

    PRINCIPAL INVESTIGATOR

Central Study Contacts

MIRIAM MLB LINERO BOCANEGRA, FISIOTERAPEUTA

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Three intervention arms: 1. Therapeutic physical exercise 2. Therapeutic physical exercise + electrotherapy 3. Therapeutic physical exercise + gamified game
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapy

Study Record Dates

First Submitted

November 24, 2025

First Posted

December 24, 2025

Study Start

February 1, 2026

Primary Completion

March 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

January 9, 2026

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations